- Home
- ADVB vs ERNA Comparison
ADVB vs ERNA Comparison
Compare ADVB & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- ERNA
- Stock Information
- Founded
- ADVB 2014
- ERNA 2018
- Country
- ADVB United States
- ERNA United States
- Employees
- ADVB N/A
- ERNA N/A
- Industry
- ADVB Medical Specialities
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- ADVB Health Care
- ERNA Health Care
- Exchange
- ADVB Nasdaq
- ERNA Nasdaq
- Market Cap
- ADVB 12.2M
- ERNA 10.2M
- IPO Year
- ADVB 2025
- ERNA N/A
- Fundamental
- Price
- ADVB $0.47
- ERNA $1.34
- Analyst Decision
- ADVB
- ERNA
- Analyst Count
- ADVB 0
- ERNA 0
- Target Price
- ADVB N/A
- ERNA N/A
- AVG Volume (30 Days)
- ADVB 258.4K
- ERNA 201.7K
- Earning Date
- ADVB 11-03-2025
- ERNA 11-11-2025
- Dividend Yield
- ADVB N/A
- ERNA N/A
- EPS Growth
- ADVB N/A
- ERNA N/A
- EPS
- ADVB N/A
- ERNA N/A
- Revenue
- ADVB N/A
- ERNA $488,000.00
- Revenue This Year
- ADVB N/A
- ERNA N/A
- Revenue Next Year
- ADVB N/A
- ERNA N/A
- P/E Ratio
- ADVB N/A
- ERNA N/A
- Revenue Growth
- ADVB N/A
- ERNA 201.24
- 52 Week Low
- ADVB $0.34
- ERNA $1.09
- 52 Week High
- ADVB $4.10
- ERNA $18.75
- Technical
- Relative Strength Index (RSI)
- ADVB 50.82
- ERNA 52.65
- Support Level
- ADVB $0.43
- ERNA $1.09
- Resistance Level
- ADVB $0.65
- ERNA $1.39
- Average True Range (ATR)
- ADVB 0.05
- ERNA 0.09
- MACD
- ADVB 0.00
- ERNA 0.04
- Stochastic Oscillator
- ADVB 28.15
- ERNA 77.42
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.